Can Wegovy help you get pregnant — and is it safe to try?

Why weight loss before conception can matter, and where Wegovy fits

There is solid evidence that excess weight can disrupt the hormonal signals that regulate ovulation. Conditions like polycystic ovary syndrome (PCOS), which is closely associated with insulin resistance, are a well-recognised cause of reduced fertility and are far more common in people living with obesity. Clinicians have therefore long supported weight reduction as a pre-conception strategy, not as a guarantee, but as one factor that can meaningfully shift the odds.

Where semaglutide enters that picture is through its effect on appetite, food intake, and for some people insulin sensitivity. Weight loss achieved on Wegovy has been shown in clinical trials to be substantial: the STEP 1 trial, published in the New England Journal of Medicine, found an average body-weight reduction of around 15% over 68 weeks at the 2.4 mg maintenance dose. For someone whose fertility has been disrupted by weight-related hormonal imbalance, that scale of loss could be clinically significant before a pregnancy attempt. The difficulty is timing. The medicine needs to be stopped (and kept stopped) before and during pregnancy, which requires planning.

A quick practical check worth doing now: the NHS BMI calculator takes under a minute and gives you a concrete starting point for any conversation with your GP or fertility specialist. Your number alone does not determine anything, but it helps frame the clinical discussion.

The specific safety concern: why Wegovy stops at conception

Animal studies with semaglutide showed effects on foetal development at doses relevant to humans. That evidence is enough for regulators and prescribers to treat this as a firm contraindication during pregnancy. The NHS England guidance on weight-management injections is explicit: these medicines are not suitable during pregnancy or for people who are trying to conceive.

There is also a practical concern specific to oral contraceptives. Semaglutide slows gastric emptying, and for people taking the pill this may affect absorption. Your prescriber can advise on whether an additional method is appropriate for as long as you remain on treatment.

The question of how long to stop before trying to conceive is one for your prescriber. Semaglutide has a half-life of around one week, meaning it clears the body more quickly than some medicines, but the right gap depends on your individual situation and should not be decided without clinical input. If you are already on Wegovy and your plans around conception have changed, that conversation should happen sooner rather than later. You can find out more about the practical side of this on our page about taking Wegovy when trying to get pregnant.

What happens if you become pregnant while on Wegovy

Accidents happen, and if you are wondering whether you can get pregnant on Wegovy, our dedicated page covers the key factors, including how the medicine may interact with contraception and what the evidence says about fertility during treatment. Becoming pregnant while on Wegovy does not mean harm has occurred, but it does mean stopping immediately and telling your GP and obstetric team. Do not wait for your next scheduled review. Early disclosure allows your care team to monitor appropriately and log the exposure, which also supports the post-marketing safety data that regulators rely on.

If you would like to read through the specifics of that scenario, our page on what to do if you become pregnant on Wegovy covers the steps clearly, and the page on Wegovy and pregnancy sets out the broader regulatory picture. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk is also available for reporting unexpected events during treatment, including pregnancies.

Making the decision: a staged approach most clinicians support

The framework most GPs and reproductive specialists would recognise is roughly this: lose weight to a point that improves your reproductive profile, stop the medicine with enough lead time before actively trying, then proceed. How long, how much weight, and exactly when to stop are individual clinical decisions. Wegovy does not cause infertility; it is a medicine that needs to be paused at the right moment rather than avoided altogether if weight management is genuinely part of your pre-conception plan.

That framing also matters for anyone who has been told by a fertility clinic that reducing weight is a condition of treatment, IVF centres in the UK commonly set BMI thresholds. Weight lost with clinical support before that threshold conversation can make a real difference. Our weight-loss treatment overview sets out the options currently available through a regulated private pharmacy, and our guide to Wegovy and pregnancy addresses the safety evidence in more depth.

A prescriber at a service like ours can review your situation, discuss the timing question honestly, and if treatment is appropriate, support you through it. If you are close to starting a fertility journey, that conversation is the right next step. Start your free consultation and a GPhC-registered prescriber will review your details the same day.